XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.3791
+0.0341 (9.88%)
At close: Oct 2, 2026, 4:00 PM EDT
1.650
+1.271 (335.24%)
After-hours: Oct 2, 2026, 7:00 PM EDT
XORTX Therapeutics Market Cap
XORTX Therapeutics has a market cap or net worth of $3.11 million as of October 2, 2026. Its market cap has decreased by -26.79% in one year.
Market Cap
3.11M
Enterprise Value
2.12M
1-Year Change
-26.79%
Ranking
Category
Stock Price
$0.38
ChartMarket Cap Chart
Since November 28, 2018, XORTX Therapeutics's market cap has decreased from $9.01M to $3.11M, a decrease of -65.44%. That is a compound annual growth rate of -12.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 3.11M | -20.42% |
| Dec 31, 2025 | 3.91M | -0.50% |
| Dec 31, 2024 | 3.93M | -14.83% |
| Dec 29, 2023 | 4.62M | -60.29% |
| Dec 30, 2022 | 11.63M | -56.34% |
| Dec 31, 2021 | 26.63M | 182.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jupiter Neurosciences | 3.36M |
| Cadrenal Therapeutics | 3.35M |
| Propanc Biopharma | 3.21M |
| Addex Therapeutics | 3.19M |
| Aptevo Therapeutics | 3.17M |
| HCW Biologics | 3.09M |
| Revelation Biosciences | 3.04M |
| VivoSim Labs | 2.92M |